Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 HKD | -4.23% | -25.27% | -65.66% |
Business Summary
Number of employees: 100
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 92 | 100.0 % | 114 | 100.0 % | +23.78% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
54.3
%
| 37 | 39.9 % | 62 | 54.3 % | +68.60% |
Other Regions
45.7
%
| 55 | 60.1 % | 52 | 45.7 % | -5.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 19-04-01 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Minnie Ke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qian Ma
CMP | Compliance Officer | - | 21-06-20 |
Pauline Li
COO | Chief Operating Officer | - | 22-05-07 |
Isabella Zhao
IRC | Investor Relations Contact | - | - |
Zhang Wei
PRN | Corporate Officer/Principal | - | - |
Hu Tianxin
PRN | Corporate Officer/Principal | - | - |
Chris Chen
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 22-07-04 |
James Geraghty
BRD | Director/Board Member | 69 | 18-07-17 |
Peng Kuan Chan
BRD | Director/Board Member | 60 | 21-06-10 |
Lan Hu
BRD | Director/Board Member | 55 | 22-02-15 |
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Richard Gregory
BRD | Director/Board Member | 66 | 20-04-20 |
53 | - | ||
Kan Chen
BRD | Director/Board Member | 42 | 20-12-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 424,838,320 | 382,362,890 ( 90.00 %) | 0 | 90.00 % |
Company contact information
CANbridge Pharmaceuticals Inc.
Suite 301, 3F, TImeloit No. 17 RongChuang Road
, Beijing
+86 10 8414 8018
http://www.canbridgepharma.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.66% | 19.3M | |
+7.91% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+20.84% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |
- Stock Market
- Equities
- 1228 Stock
- Company CANbridge Pharmaceuticals Inc.